For the first time since late 2012, Obamacare may have slightly more fans than foes, a survey says.» Read More
A separate US appeals court upheld a federal regulations that implemented subsidies that are vital to President Obama's healthcare overhaul.
Allergan on Monday said that its second-quarter profit and sales rose, and it announced $475 million in cost cuts.
Valeant has complained to regulators that claims made by Allergan to counter a hostile takeover are misleading, sources have told CNBC.
A decision by a Florida jury to impose damages of $23.6 billion against RJ Reynolds is likely to be rejected or reduced on appeal, experts say.
FedEx's indictment for shipping packages from illegal online pharmacies isn't hurting shares, which makes sense to one analyst.
Several court challenges to a key part of Obamacare could lead to average premium increases of 76 percent for subsidized HealthCare.gov enrollees.
U.S. drugmaker announces plans to take over Dublin-based Shire in a deal that will help AbbVie lower its tax rate by buying a foreign rival.
FedEx was indicted for shipping packages from illegal online pharmacies despite repeated warnings from U.S. drug enforcement officials.
Over 100 AIDS activists on route to a conference in Melbourne were on board MH17 which crashed in Ukraine, several Australian media sources reported.
States may be on the hook for $55 billion to pay for hepatitis C treatments like Sovaldi, a new study says.
Sanofi talked with Abbott Laboratories, Mylan and private equity firms over selling a portfolio of mature drugs, according to a document.
Novartis and Google have agreed to develop "smart" contact lenses to help diabetics track blood glucose levels or restore the eye's ability to focus.
Many choose to hire a caregiver through a geriatric care manager, or GCM, or by finding someone on their own.
Most millennials use alternative medicine to maintain wellbeing rather than cure existing sicknesses. The Fiscal Times reports.
A huge merger between tobacco giants Reynolds American and Lorillard will see electronic cigarette leader blu go to another company.
Hundreds have died in West Africa from the Ebola virus. With no known cure and a high mortality rate, alarm is real.
The liver disease NASH is becoming more widespread, and the market for treatments may rival those for hepatitis C.
Venture capital investment in health-care IT companies has topped $2.3 billion in 2014, blowing past the $1.9 billion in funding for all of 2013.
Some users find that their bands actually make them pack on the pounds as opposed to shedding weight. The TODAY Show reports.
Sales of newer prescription drugs helped boost Johnson & Johnson's earnings to a level much higher than expected.
Get the best of CNBC in your inbox